Project Consultancy, Reports & Profiles

India's healthcare business landscape is entering a decisive growth phase, and entrepreneurs looking for solid business ideas should take note. The sector already touches nearly every corner of the economy, from hospitals and diagnostics to medical device manufacturing and pharmaceuticals.

Rising incomes, growing insurance coverage, and an ageing population are pushing demand higher every year. At the same time, India still imports a large share of its medical equipment, which leaves plenty of room for domestic producers to step in.

For anyone exploring healthcare and medical business ideas in India, this is a good moment to look closely at where the real openings lie, from small diagnostic labs to full-scale device manufacturing plants.

The sector also benefits from a policy environment that has grown far more supportive over the past five years. Production-linked incentives, tax breaks, and easier clearances have turned what used to be a slow, capital-heavy industry into one where mid-sized entrepreneurs can realistically compete.

This piece walks through the current market numbers, the government support available, and the practical cost ranges founders should expect, so the decision to enter this space rests on data rather than assumption.

Why This Sector Is a Smart Choice for New Entrepreneurs

Healthcare demand in India rarely slows down. Chronic disease rates are climbing, and so is awareness around early diagnosis and preventive care. This steady, non-cyclical demand is one reason a medical business tends to hold up even when other sectors slow.

Export potential adds another layer of opportunity. India's medical devices and pharmaceutical exports have grown steadily, and government incentives are actively pushing manufacturers to sell abroad, not just serve the domestic market.

Profitability in this sector tends to be stronger than in many manufacturing categories because margins on diagnostics, specialty devices, and hospital services are structurally high. Timing matters too: with PLI scheme for medical devices incentives running through FY 2026-27, new entrants who set up now can still capture policy support before the window narrows.

Consider also how import dependence works in an entrepreneur's favour here. India still brings in a large share of its high-end medical equipment from abroad, which means every rupee spent on imports today is a potential sale for a domestic manufacturer tomorrow. Few sectors offer such a clear, government-backed roadmap for import substitution.

Labour and skill availability add further support. India trains a large pool of doctors, nurses, and biomedical engineers every year, which keeps staffing costs for new ventures more manageable compared with many developed markets entering the same space.

Market Demand & Statistics

Demand for healthcare manufacturing output comes from a wide base of buyers. Hospitals and nursing homes remain the single largest end-user group, followed by diagnostic chains, government procurement agencies, and export markets.

India's hospital market alone stood at roughly US$ 98.98 billion in FY23 and is projected to grow at about 8% CAGR to reach US$ 193.59 billion by FY32 (industry association estimates). Diagnostic equipment demand is following a similar upward curve, supported by a national push toward wider insurance coverage.

Medical tourism is a fast-rising demand pool too. The segment was valued near US$ 8.71 billion in 2025 and is projected to touch US$ 16.21 billion by 2030, at a CAGR of roughly 13% (industry estimates), which directly benefits hospitals, diagnostics, and device suppliers serving international patients.

End-user breakdown matters when planning a new venture. Public hospitals and government procurement drive volume-led demand, private hospital chains drive premium and specialty demand, and export buyers drive demand for devices meeting international quality certifications. Each buyer group needs a different approach to pricing, compliance, and sales.

India's registered healthcare workforce is also expanding fast, with over 43 new medical colleges added in 2025-26 alone, according to IBEF data. A larger trained workforce means faster absorption capacity for new diagnostic centres, clinics, and hospital beds coming online.

Government Policies, Incentives & Facilities

Central government support for this sector is substantial. The PLI scheme for medical devices carries a total outlay of Rs. 3,420 crore, offering a 5% incentive on incremental sales for five years across four target segments, including cancer care, radiology, and anaesthetics equipment (Department of Pharmaceuticals data).

Alongside PLI, the Scheme for Strengthening of Medical Device Industry (SMDI) supports smaller manufacturers through the Marginal Investment Scheme for Reducing Import Dependence (MIS-RID) and Common Facilities for Medical Devices Clusters (CFMDC). MSMEs entering this space can also tap CGTMSE for collateral-free loans and CLCSS for technology upgradation support.

Startup India registration brings tax benefits and easier compliance for new ventures, while the RoDTEP export incentive scheme helps offset input costs for manufacturers shipping medical products overseas. At the state level, Telangana's Life Sciences policy and Gujarat's medical device park initiatives offer land, power subsidies, and single-window clearances for healthcare business ideas for entrepreneurs setting up manufacturing units.

The Scheme for Promotion of Medical Device Parks adds another layer of support, offering a grant of up to Rs. 100 crore per park to states building shared manufacturing infrastructure. This lowers upfront capital needs for smaller manufacturers who would otherwise struggle to build standalone facilities.

Entrepreneurs should also track Union Budget allocations closely. Budget 2026-27 raised funding for the Department of Health and Family Welfare significantly, a signal that public procurement of devices, diagnostics, and hospital infrastructure will keep expanding over the next few years.

Market Growth & Industry Outlook

Growth in this sector is being driven by a mix of demographic and policy factors. India's population is ageing gradually, insurance penetration is rising from a low base, and digital health adoption is accelerating diagnosis and treatment access in smaller towns.

Overall, India's healthcare sector is growing at an estimated 8-12% annually, while digital health and diagnostics are expanding even faster, in the 20-35% range by some industry estimates. This uneven growth pattern means new entrants should study sub-segments carefully rather than treating healthcare business as one uniform opportunity.

Consolidation is another trend shaping the outlook. Larger hospital chains and diagnostics groups have been acquiring smaller regional players, which suggests that scale and specialised service offerings will matter more over the next decade than simple geographic spread.

Year-Wise Market Data (Historical and Forecast to 2035)

The table below presents India's healthcare market size trend. Figures beyond 2026 are forecasts built on an assumed CAGR of 10-11%, based on the historical growth range reported across multiple industry sources; treat these as directional estimates, not confirmed data.

Market Forecast to 2035

By 2035, India's healthcare market could realistically cross US$ 800 billion, assuming the sector sustains a 10-11% compound annual growth rate from its current FY26 base of roughly US$ 400 billion (industry estimate, assumption stated clearly). This is not an official projection but a reasonable extrapolation drawn from current growth trends.

Medical device manufacturing is likely to grow faster than the overall sector average, given the strong policy push through PLI and Medical Device Parks. If this segment sustains its projected 2025-2030 trajectory, India's device market alone could realistically exceed US$ 90 billion by 2035.

Import–Export Opportunity Analysis

India still imports a large share of high-end medical devices, including MRI machines, CT scanners, and linear accelerators. This import dependence is exactly the kind of gap that a medical equipment manufacturing machinery suppliers India search points new entrepreneurs toward.

On the export side, the trend is encouraging. Pharmaceutical exports touched US$ 30.5 billion in FY25, and cumulative sales under the medical devices PLI scheme have already crossed Rs. 8,000 crore, including over Rs. 3,800 crore in exports (Department of Pharmaceuticals data, as of September 2024).

India's exports of medical devices and pharmaceuticals grew steadily through the past few years — industry estimates put the combined export growth in the high single digits to low double digits annually.

New manufacturers entering categories flagged under the PLI scheme, such as imaging equipment and radiotherapy devices, stand to benefit twice over: once from import substitution within India, and again from export incentives once quality certifications are in place. This dual benefit is rare among manufacturing sectors and worth factoring into any long-term business plan.

Major Indian Players

The table below lists established Indian companies active across hospitals, diagnostics, pharmaceuticals, and medical devices, offering useful benchmarks for new entrants studying scale and specialization.

Future Growth Potential & Reasons to Consider This Sector

Digital health, AI-assisted diagnostics, and home healthcare are opening fresh sub-categories within the wider healthcare business space. These segments require lower upfront capital than a full hospital, making them attractive entry points for first-time investors.

Tier-2 and tier-3 cities remain underserved in diagnostics and specialty care, which means location-based opportunity still exists outside the metros. Government spending on rural healthcare infrastructure continues to rise each budget cycle, adding another demand layer for equipment suppliers and service providers.

Private equity and venture capital interest in Indian healthcare has also stayed strong, with recent funding rounds going into AI-driven diagnostics, cloud-based hospital management platforms, and specialty cancer care networks. This capital availability makes it easier for new entrants to scale once the initial business model proves out.

Cost & Investment Data

Investment requirements vary widely depending on the format chosen. The table below gives a rough range for common formats within healthcare and medical business ideas in India, useful for early budgeting before a detailed project report is prepared.

FAQ

How much investment is needed to start a diagnostic centre in India?

A small diagnostic lab can start with Rs. 15-50 lakh, mainly for equipment and lease costs, while larger multi-modality centres need proportionately more.

What government schemes support medical device manufacturing in India?

The medical devices PLI scheme India is the primary support mechanism, alongside SMDI, MIS-RID, CGTMSE, and state-level medical device park incentives.

Is a hospital project cost and investment in India realistic for a first-time entrepreneur?

A full hospital needs significant capital, but smaller nursing homes or 30-bed facilities are a realistic entry point before scaling toward a larger hospital project cost and investment in India commitment.

Which Indian states offer the best incentives for healthcare manufacturing?

Telangana, Gujarat, and Tamil Nadu currently offer strong incentives through life sciences policies, medical device parks, and single-window clearance systems.

How do I start a medical device manufacturing business in India?

Begin with a detailed project report, register under Startup India or MSME, secure BIS/CDSCO approvals as applicable, and evaluate medical equipment manufacturing machinery suppliers India before finalising the plant layout.

Are medical exports from India growing?

Yes. Pharmaceutical exports reached US$ 30.5 billion in FY25, and medical device export value under the PLI scheme has crossed Rs. 3,800 crore, both pointing to steady growth.

The Bottom Line

India's healthcare business sector offers a rare combination: steady demand, active government backing, and clear gaps in domestic manufacturing capacity. Entrepreneurs who study the specific sub-segment carefully, whether diagnostics, devices, or hospital services, stand a genuine chance of building a durable business in this space over the next decade.

References

India Brand Equity Foundation (IBEF) — healthcare and medical devices market size and growth data.

Press Information Bureau, Government of India — Production Linked Incentive Scheme for medical devices, financial outlay and progress.

Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers — PLI scheme implementation and cumulative sales data.

PRS Legislative Research — parliamentary committee findings on medical device industry promotion.

Make in India portal, Department for Promotion of Industry and Internal Trade — scheme details for medical device manufacturing.

Economic Survey 2025-26, Ministry of Finance — pharmaceutical export figures and sector positioning.